Akebia Therapeutics' Angel Round

Akebia Therapeutics raised a round of funding on , . Investors include Queen City Angels.

Akebia Therapeutics is focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Akebia's lead product candidate, vadadustat, is an inv…

Articles about Akebia Therapeutics' Angel Round: